13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001802451
Total reported value
$298.5M
$298.5M
616 檔
38.1%
At the close of Q2 2025, HighMark Wealth Management LLC disclosed equity holdings valued at approximately $298.5M, spread across 616 reported holdings.
During Q2 2025, HighMark Wealth Management LLC's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
Showing top 200 holdings (of 616 total)
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | IVV | Ishares Core S&p 500 ETF | ETF-Large Cap & Growth | 33.43% | -3.44% | +0.62% | |
| 2 | EFV | Ishares Msci Eafe Value ETF | ETF-Other | 7.22% | -1.56% | -6.19% | |
| 3 | IWM | Ishares Russell 2000 ETF | ETF-Small Cap | 5.85% | -0.38% | -2.87% | |
| 4 | IJR | Ishares Core S&p Small-cap E | ETF-Small Cap | 4.63% | -0.11% | +1.72% | |
| 5 | VOO | Vanguard S&p 500 ETF | ETF-Large Cap & Growth | 4.46% | -0.43% | +2462.36% | |
| 6 | IUSV | Ishares Core S&p U.s. Value | ETF-Other | 3.58% | -0.55% | +0.12% | |
| 7 | WFC | Wells Fargo & Co | Stock-Financials | 2.93% | -0.32% | +0.04% | |
| 8 | DWAS | Invesco Dorsey Wright Smallc | ETF-Other | 1.96% | +0.11% | -0.03% | |
| 9 | IJH | Ishares Core S&p Midcap ETF | ETF-Other | 1.76% | -0.05% | +1.90% | |
| 10 | PFMTUSD | Performant Financial CORP | Stock-Other | 1.59% | — | -0.49% | |
| 11 | ANAB | Anaptysbio Inc | Stock-Other | 1.58% | -1.22% | +58.21% | |
| 12 | TLT | Ishares 20+ Year Treasury Bd | ETF-Gov Bonds | 1.53% | -0.21% | — | |
| 13 | 260 | Centessa Pharmaceuticals-adr | Stock-Other | 1.52% | -3.83% | EXIT | |
| 14 | ATRC | Atricure Inc | Stock-Other | 1.34% | -0.19% | — | |
| 15 | NVDA | Nvidia CORP | Stock-Tech | 1.01% | -0.12% | -0.94% | |
| 16 | MSFT | Microsoft CORP | Stock-Tech | 0.90% | -0.09% | +18.62% | |
| 17 | AAPL | Apple Inc | Stock-Tech | 0.84% | -0.07% | +18.19% | |
| 18 | MMM | 3m Co | Stock-Industrials | 0.73% | -0.05% | +12.77% | |
| 19 | TRV | Travelers Cos Inc/the | Stock-Financials | 0.73% | -0.04% | +0.02% | |
| 20 | TWST | Twist Bioscience CORP | Stock-Other | 0.69% | +0.59% | +12126.98% | |
| 21 | LLY | Eli Lilly & Co | Stock-Healthcare | 0.65% | +0.05% | -0.41% | |
| 22 | IJJ | Ishares S&p Mid-cap 400 Valu | ETF-Other | 0.57% | -0.01% | +2698.23% | |
| 23 | IVE | Ishares S&p 500 Value ETF | ETF-Large Cap & Growth | 0.56% | -0.04% | +2560.18% | |
| 24 | ORGO | Organogenesis Holdings Inc | Stock-Other | 0.52% | -0.28% | — | |
| 25 | AXGN | Axogen Inc | Stock-Other | 0.52% | +0.63% | +174.48% | |
| 26 | ATEC | Alphatec Holdings Inc | Stock-Other | 0.51% | -0.08% | — | |
| 27 | LQD | Ishr Ibx Usd Invgd Cb Etf-ui | ETF-Corp Bonds | 0.48% | -0.06% | — | |
| 28 | IWN | Ishares Russell 2000 Value E | ETF-Small Cap | 0.48% | +0.02% | — | |
| 29 | NEO | Neogenomics Inc | Stock-Healthcare | 0.45% | +1.24% | — | |
| 30 | AGG | Ishares Core U.s. Aggregate | ETF-Other | 0.44% | -0.06% | +53305.88% | |
| 31 | XEL | Xcel Energy Inc | Stock-Utilities | 0.43% | -0.07% | +73.78% | |
| 32 | TSLA | Tesla Inc | Stock-Consumer Disc | 0.40% | -0.03% | — | |
| 33 | PG | Procter & Gamble Co/the | Stock-Consumer Staples | 0.40% | -0.04% | +45.24% | |
| 34 | XENE | Xenon Pharmaceuticals Inc | Stock-Other | 0.40% | -0.07% | +327.87% | |
| 35 | SPEM | State Street Sp Ptf Em ETF | ETF-Other | 0.39% | -0.06% | -1.64% | |
| 36 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 0.38% | — | +2.03% | |
| 37 | USB | US Bancorp | Stock-Financials | 0.37% | -0.02% | -39.84% | |
| 38 | VTI | Vanguard Total Stock Mkt ETF | ETF-Other | 0.37% | -0.01% | — | |
| 39 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 0.36% | -0.03% | -18.62% | |
| 40 | NPCE | Neuropace Inc | Stock-Other | 0.34% | +0.53% | +2000.00% | |
| 41 | EWTX | Edgewise Therapeutics Inc | Stock-Other | 0.33% | +0.04% | +31454.55% | |
| 42 | HCAT | Health Catalyst Inc | Stock-Other | 0.30% | +0.12% | +13080.00% | |
| 43 | INSM | Insmed Inc | Stock-Healthcare | 0.30% | -0.01% | — | |
| 44 | ABT | Abbott Laboratories | Stock-Healthcare | 0.29% | -0.05% | — | |
| 45 | CRNX | Crinetics Pharmaceuticals In | Stock-Other | 0.28% | +0.18% | — | |
| 46 | BRK-B | Berkshire Hathaway Inc-cl B | Stock-Other | 0.28% | -0.01% | +83.96% | |
| 47 | EVH | Evolent Health Inc - A | Stock-Other | 0.28% | — | +55.77% | |
| 48 | ECL | Ecolab Inc | Stock-Materials | 0.27% | -0.03% | +3.07% | |
| 49 | HSBC | Hsbc Holdings Plc-spons Adr | Stock-Financials | 0.27% | -0.01% | — | |
| 50 | COST | Costco Wholesale CORP | Stock-Consumer Staples | 0.24% | -0.05% | — |
According to official SEC Form 13F filings, HighMark Wealth Management LLC reported a total U.S. public equity portfolio value of $298.5M across 616 disclosed positions in Q2 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including IVV, EFV, IWM) accounted for 38.1% of total reported equity market value during Q2 2025.
During Q2 2025, HighMark Wealth Management LLC's top holdings by market value included IVV (33.4%)、EFV (7.2%)、IWM (5.8%). The largest single position, IVV, represented 33.4% of total portfolio value.
In Q2 2025, HighMark Wealth Management LLC made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.